No Data
No Data
FDA Approves Genentech's TNKase In Acute Ischemic Stroke In Adults
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Reported Sunday, Roche's Genentech Phase III Study Finds Xolair More Effective And Safer Than Oral Immunotherapy For Food Allergies
Roche Gets Positive EU Regulatory Opinion for Columvi
WHO Maintains Public Health Emergency Alert on Mpox
Berenberg Keeps Roche at Hold, Awaits Further Evidence of Pipeline Turnaround